First Trust NYSE Arca Biotechnology Index Fund Stock Forecast, Price & News

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Frequently Asked Questions

How has First Trust NYSE Arca Biotechnology Index Fund's stock been impacted by COVID-19 (Coronavirus)?

First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $131.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, FBT shares have increased by 16.9% and is now trading at $153.34.
View which stocks have been most impacted by COVID-19.

What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology Index Fund investors own include Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Walt Disney (DIS), Annaly Capital Management (NLY), ONEOK (OKE), Valero Energy (VLO), AbbVie (ABBV), Broadcom (AVGO) and Bristol-Myers Squibb (BMY).

What is First Trust NYSE Arca Biotechnology Index Fund's stock symbol?

First Trust NYSE Arca Biotechnology Index Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FBT."

Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders?

First Trust NYSE Arca Biotechnology Index Fund's stock is owned by many different institutional and retail investors. Top institutional shareholders include Morgan Stanley (7.84%), UBS Group AG (3.57%), LPL Financial LLC (2.66%), Raymond James Financial Services Advisors Inc. (1.85%), Royal Bank of Canada (1.78%) and Raymond James & Associates (1.38%).

Which institutional investors are selling First Trust NYSE Arca Biotechnology Index Fund stock?

FBT stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, LPL Financial LLC, Raymond James & Associates, Flow Traders U.S. LLC, Kestra Advisory Services LLC, Royal Bank of Canada, Citigroup Inc., and Avantax Advisory Services Inc..

Which institutional investors are buying First Trust NYSE Arca Biotechnology Index Fund stock?

FBT stock was purchased by a variety of institutional investors in the last quarter, including Ameritas Investment Company LLC, Q3 Asset Management, Truist Financial Corp, Pacific Sun Financial Corp, HBW Advisory Services LLC, Bank of Nova Scotia, Adviser Investments LLC, and Karp Capital Management Corp.

How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund?

Shares of FBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is First Trust NYSE Arca Biotechnology Index Fund's stock price today?

One share of FBT stock can currently be purchased for approximately $153.34.

How much money does First Trust NYSE Arca Biotechnology Index Fund make?

First Trust NYSE Arca Biotechnology Index Fund has a market capitalization of $1.63 billion.